J. Corry

发表

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02.

R. Fisher, L. Peters, R. Hicks, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety and cost analysis of an (18)FDG-PET-CT response based follow-up strategy for head and neck cancers treated with primary radiation or chemoradiation.

D. Rischin, J. Corry, K. Shah, 2015, Oral oncology.

Surgical margins in head and neck cancer: A contemporary review

Michael L. Hinni, Raja R. Seethala, Robert P. Takes, 2013, Head & neck.

International Guideline on Dose Prioritization and Acceptance Criteria in Radiotherapy Planning for Nasopharyngeal Carcinoma.

V. Grégoire, K. Harrington, G. Sanguineti, 2019, International journal of radiation oncology, biology, physics.

Reducing posttreatment dysphagia: Support for the relationship between radiation dose to the pharyngeal constrictors and swallowing outcomes.

J. Corry, M. Collins, S. Senthi, 2013, Practical radiation oncology.

The role of PET-CT in the management of patients with advanced cancer of the head and neck

L. Peters, R. Hicks, D. Rischin, 2008, Current oncology reports.

Current management of stage IV nasopharyngeal carcinoma without distant metastasis.

A. Mäkitie, W. Mendenhall, J. Langendijk, 2020, Cancer treatment reviews.

Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation.

L. Peters, D. Rischin, J. Corry, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

N2‐N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders—Results of Trans Tasman Radiation Oncology Group Study 98.02

R. Fisher, L. Peters, D. Rischin, 2008, Head & neck.

Radiation-Induced Sarcomas of the Head and Neck: A Systematic Review

A. Mäkitie, A. Eisbruch, W. Mendenhall, 2020, Advances in Therapy.

The 'QUAD SHOT'--a phase II study of palliative radiotherapy for incurable head and neck cancer.

L. Peters, D. Rischin, S. Porceddu, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Easing acceleration of head and neck chemoradiotherapy.

P. Strojan, A. Ferlito, M. Haigentz, 2012, The Lancet. Oncology.

Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?

A. Eisbruch, W. Mendenhall, C. Bradford, 2016, European Archives of Oto-Rhino-Laryngology.

Radiation therapy quality assurance in head and neck radiotherapy - Moving forward.

Lachlan McDowell, J. Corry, 2019, Oral oncology.

Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion.

W. Mendenhall, C. Bradford, P. Strojan, 2012, Oral oncology.

Promising results with chemoradiation in patients with sinonasal undifferentiated carcinoma

L. Weih, L. Peters, D. Rischin, 2004, Head & neck.

Psychological distress (depression and anxiety) in people with head and neck cancers

D. Castle, T. Trauer, J. Corry, 2010, The Medical journal of Australia.

Aggressive behavior of Cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia

J. Corry, A. Sizeland, H. Gavriel, 2014, The Laryngoscope.

Clinical impact of, and prognostic stratification by, F‐18 FDG PET/CT in head and neck mucosal squamous cell carcinoma

L. Peters, A. Hogg, R. Hicks, 2007, Head & neck.

Understanding Interactions of Smoking on Prognosis of HPV-Associated Oropharyngeal Cancers

C. Bradford, P. Strojan, A. Rinaldo, 2018, Advances in Therapy.

p16‐positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high‐risk human papillomavirus or prognosis and implications for the workup of the unknown primary

B. Solomon, D. Rischin, Lachlan McDowell, 2016, Cancer.

T4 squamous cell carcinoma of the oral tongue without mandibular involvement: surgery or chemoradiotherapy?

D. Rischin, Lachlan McDowell, J. Corry, 2014, Oral surgery, oral medicine, oral pathology and oral radiology.

International Recommendations on Re-irradiation by Intensity-modulated Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma.

V. Grégoire, K. Harrington, G. Sanguineti, 2021, International journal of radiation oncology, biology, physics.

Current trends in initial management of oropharyngeal cancer: the declining use of open surgery

E. Genden, C. Silver, A. Rinaldo, 2009, European Archives of Oto-Rhino-Laryngology.

Impact of center size and experience on outcomes in head and neck cancer.

L. Peters, D. Rischin, J. Corry, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

When is chemotherapy in head and neck squamous cell carcinoma not indicated?

W. Mendenhall, C. Bradford, G. Wolf, 2015, European Archives of Oto-Rhino-Laryngology.

The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.

V. Grégoire, J. Machiels, B. Weynand, 2012, Oral oncology.

Utility of positron emission tomography/computed tomography for nodal staging of cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.

J. Corry, E. Lau, Jonathan M Tomaszewski, 2014, American journal of otolaryngology.

Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma

R. Fisher, S. Fox, B. Solomon, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Proton Therapy for Squamous Cell Carcinoma of the Head and Neck: Early Clinical Experience and Current Challenges

A. Eisbruch, W. Mendenhall, P. Strojan, 2022, Cancers.

Prognostic stratification of HPV associated oropharyngeal cancer based on CD103+ immune cell abundance in patients treated on TROG 12.01 and De-ESCALaTE randomised trials.

B. Solomon, D. Rischin, J. Dunn, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?

A. Sanabria, R. de Bree, A. Mäkitie, 2021, Oral oncology.

Outcomes of curative (chemo)radiotherapy for patients with non‐p16 positive head and neck squamous cell carcinoma who are borderline for curative treatment

D. Rischin, M. Bressel, J. Corry, 2020, Journal of Medical Imaging and Radiation Oncology.

Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement

A. Garden, V. Grégoire, K. Harrington, 2020, International Journal of Radiation Oncology*Biology*Physics.

Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group study.

B. Solomon, D. Rischin, S. Porceddu, 2020, Oral oncology.

Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement

A. Garden, V. Grégoire, K. Harrington, 2020, Radiotherapy and Oncology.

Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma

S. Fox, B. Solomon, S. Hendry, 2018, Cancer Immunology Research.

Should all mucosal head and neck cancer patients be treated in high volume centres, or can some be appropriately triaged to local centres for treatment

J. Corry, 2016, Journal of medical imaging and radiation oncology.

Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus–positive oropharyngeal squamous cell carcinoma

B. Solomon, L. Peters, D. Rischin, 2016, Head & neck.

The Multidisciplinary Approach Needs to Extend Into Head and Neck Cancer Clinical Trials.

S. Yom, J. Corry, 2016, International journal of radiation oncology, biology, physics.

Correlation of p16 status, hypoxic imaging using [18F]‐misonidazole positron emission tomography and outcome in patients with loco‐regionally advanced head and neck cancer

R. Fisher, B. Solomon, L. Peters, 2014, Journal of medical imaging and radiation oncology.

Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer.

B. Rose, M. Chatfield, C. S. Lee, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Reply to the letter to the editor by Straetmans et al

E. Genden, J. Werner, R. de Bree, 2012 .

Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma.

L. Weih, L. Peters, D. Rischin, 2004, International journal of radiation oncology, biology, physics.

Disadvantaged Subgroups Within the Global Head and Neck Cancer Population: How Can We Optimize Care?

Anurag K. Singh, S. Oosting, J. Corry, 2022, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009.

K. Soo, B. Anderson, R. Hicks, 2009, The Lancet. Oncology.

Treatment response in the neck: p16+ versus p16− oropharyngeal cancer

B. Solomon, L. Peters, R. Hicks, 2013, Journal of medical imaging and radiation oncology.

Planned neck dissection for patients with complete response to chemoradiotherapy: A concept approaching obsolescence

C. Silver, A. Shaha, A. Rinaldo, 2009, Head & neck.

Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.

S. Fox, B. Solomon, P. Russell, 2013, Oral oncology.

Quantitative methodology is critical for assessing DNA methylation and impacts on correlation with patient outcome

B. Solomon, H. Do, A. Dobrovic, 2014, Clinical Epigenetics.

COVID-19—An Opportunity for Optimizing Surveillance Protocols During and Beyond the Pandemic: HPV-Associated Oropharyngeal Cancer as an Example of Response-Based Local Surveillance

Lachlan McDowell, S. Ng, J. Corry, 2020, International Journal of Radiation Oncology*Biology*Physics.

Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial.

D. Rischin, B. Panizza, G. Fogarty, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework

V. Gebski, T. Kron, B. Burmeister, 2015, Journal of medical imaging and radiation oncology.

Tonsillar cancer: The Peter MacCallum experience with unilateral and bilateral irradiation

L. Peters, D. Rischin, J. Corry, 2014, Head & neck.

Recurrent and second primary squamous cell carcinoma of the head and neck: When and how to reirradiate

E. Genden, A. Eisbruch, W. Mendenhall, 2015, Head & neck.

Induction chemotherapy in head and neck cancer: closer to an answer?

D. Rischin, J. Corry, 2011, The Lancet. Oncology.

Thrombotic Thrombocytopenic Purpura in Pregnancy

M. Permezel, J. Corry, N. Lee, 1992, The Australian & New Zealand journal of obstetrics & gynaecology.

Combined modality treatment for locally advanced squamous-cell carcinoma of the oropharynx in a woman with Bloom's syndrome: a case report and review of the literature.

L. Peters, D. Rischin, J. Corry, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

A longitudinal study of distress (depression and anxiety) up to 18 months after radiotherapy for head and neck cancer

D. Castle, T. Trauer, J. Corry, 2013, Psycho-oncology.

Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.

B. Solomon, D. Rischin, S. Porceddu, 2017, International journal of radiation oncology, biology, physics.

Larynx preservation with primary non‐surgical treatment for loco‐regionally advanced larynx cancer

L. Peters, D. Rischin, J. Corry, 2011, Journal of medical imaging and radiation oncology.

Results of treatment intensification for progressive locoregional disease in head-and-neck cancer patients undergoing postoperative radiotherapy.

B. Mukesh, L. Peters, D. Rischin, 2005, International journal of radiation oncology, biology, physics.

A Call to Arms: Radiation Therapy Quality Assurance in the Next Generation of Clinical Trials.

Lachlan McDowell, J. Corry, 2018, International journal of radiation oncology, biology, physics.

The IAEA-ACC study: a commendable start.

J. Corry, 2010, The Lancet. Oncology.

Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.

R. Fisher, L. Peters, R. Hicks, 2007, International journal of radiation oncology, biology, physics.

Long‐term swallowing after chemoradiotherapy: Prospective study of functional and patient‐reported changes over time

A. Perry, J. Corry, J. Frowen, 2016, Head & neck.

Impact of demographics, tumor characteristics, and treatment factors on swallowing after (chemo)radiotherapy for head and neck cancer

A. Perry, S. Cotton, J. Corry, 2009, Head & neck.

Larynx preservation for patients with locally advanced laryngeal cancer.

L. Peters, D. Rischin, J. Corry, 2013, Journal of Clinical Oncology.

Evaluating new treatments for anaplastic thyroid cancer

J. Shah, A. Sanabria, R. Smallridge, 2022, Expert review of anticancer therapy.

A dietitian-led clinic for patients receiving (chemo)radiotherapy for head and neck cancer

N. Kiss, M. Krishnasamy, J. Corry, 2012, Supportive Care in Cancer.

Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review.

R. de Bree, N. Saba, A. Ferlito, 2022, Oral oncology.

Management of locally recurrent nasopharyngeal carcinoma.

S. Yom, A. Mäkitie, W. Mendenhall, 2019, Cancer treatment reviews.

A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.

B. Solomon, L. Peters, R. Hicks, 2013, Oral oncology.

Current Radiotherapy Considerations for Nasopharyngeal Carcinoma

W. Mendenhall, P. Strojan, J. Beitler, 2022, Cancers.

Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation

L. Peters, D. Rischin, S. Porceddu, 2009, Head & neck.

Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation

D. Rischin, J. Corry, S. Porceddu, 2008, Journal of medical imaging and radiation oncology.

Dosimetric study of optimal beam number and arrangement for treatment of nasopharyngeal carcinoma with intensity-modulated radiation therapy.

L. Peters, A. Budrukkar, J. Cramb, 2004, Australasian radiology.

Correlation of Ataxia-Telangiectasia-Mutated (ATM) gene loss with outcome in head and neck squamous cell carcinoma.

S. Fox, B. Solomon, L. Peters, 2012, Oral oncology.

Symptom duration and delay in referral for palliative radiotherapy in cancer patients: a pilot study

H. Mameghan, D. Ball, J. Corry, 1998, The Medical journal of Australia.

Prolonged remission in a patient with nasopharyngeal carcinoma with a solitary bone metastasis.

D. Rischin, J. Corry, E. Lau, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genome-scale methylation assessment did not identify prognostic biomarkers in oral tongue carcinomas

E. Zotenko, R. Pidsley, S. Clark, 2015, Clinical Epigenetics.

Parotid-sparing radiotherapy: does it really reduce xerostomia?

L. Peters, D. Rischin, S. Porceddu, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Outcomes of cutaneous squamous cell carcinoma of the head and neck with parotid metastases

Lachlan McDowell, M. Bressel, J. Corry, 2016, Journal of medical imaging and radiation oncology.

International assessment of interobserver reproducibility of flap delineation in head and neck carcinoma

S. Yom, P. Marcy, J. Salleron, 2022, Acta oncologica.

Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck

D. Gyorki, J. Corry, N. Hirshoren, 2017, Head & neck.

Post-operative concurrent chemo-radiotherapy versus post-operative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: A randomized phase III trial (Trans Tasman Radiation Oncology Group 05.01 Trial; POST study).

D. Rischin, B. Panizza, G. Fogarty, 2017 .

Treatment package time in node-positive cutaneous head and neck squamous cell carcinoma.

Lachlan McDowell, M. Bressel, J. Corry, 2019, Practical radiation oncology.

Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer.

L. Peters, D. Rischin, J. Corry, 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Short communication Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer

L. Peters, D. Rischin, J. Corry, 2000 .

Head and Neck Squamous Cell Carcinoma

R. Fisher, S. Fox, B. Solomon, 2020, Definitions.

Differential mechanisms of CDKN2A (p16) alteration in oral tongue squamous cell carcinomas and correlation with patient outcome

S. Fox, B. Solomon, H. Do, 2014, International journal of cancer.

Treatment of late sequelae after radiotherapy for head and neck cancer.

A. Eisbruch, W. Mendenhall, J. Langendijk, 2017, Cancer treatment reviews.

Pathology reporting in head and neck cancer—Snapshot of current status

J. Corry, Bronwyn King, 2009, Head & neck.

Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART).

R. Fisher, B. O'Sullivan, L. Peters, 2017, International journal of radiation oncology, biology, physics.

The concept of a planned neck dissection is obsolete.

L. Peters, J. Corry, J. Smith, 2001, Cancer journal.

Patient-reported quality of life and symptom burden measures in human papillomavirus associated oropharyngeal cancer - A review of the literature and PRO methodology.

D. Rischin, Lachlan McDowell, K. Gough, 2021, Oral oncology.

Suboptimal health literacy in patients with lung cancer or head and neck cancer

R. Buchbinder, R. Osborne, M. Jefford, 2013, Supportive Care in Cancer.

Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer

L. Weih, R. Hicks, D. Rischin, 2005, Head & neck.

Regarding "Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey" - Intra- and inter-specialty variability and the underutilisation of unilateral radiotherapy as treatment de-intensi

Lachlan McDowell, J. Corry, 2021, Oral oncology.

Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck

A. Mäkitie, W. Mendenhall, J. Langendijk, 2021, Head & neck.

Salvage radiotherapy for Hodgkin's disease following chemotherapy failure.

J. Corry, A. Wirth, Kuen Hoe Liew, 1997, International journal of radiation oncology, biology, physics.

Frequency and prognostic significance of p16 INK4A protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma

B. Solomon, D. Rischin, R. Young, 2015 .

Outcomes in sinonasal mucosal melanoma

L. Weih, S. Porceddu, J. Corry, 2004, ANZ journal of surgery.

Paranasal sinus tumors: Peter maccallum cancer institute experience

L. Weih, L. Peters, D. Rischin, 2004, Head & neck.

Nasopharyngeal Carcinoma in Nonendemic Populations

J. Corry, B. Glisson, 2012 .

Prospective trial to evaluate staged neck dissection or elective neck radiotherapy in patients with CT‐staged T1‐2 N0 squamous cell carcinoma of the oral tongue

L. Peters, D. Rischin, S. Porceddu, 2009, Head & neck.

A case of primary tracheal squamous cell carcinoma arising from malignant transformation of recurrent respiratory papillomatosis, with a complete response to concurrent chemoradiotherapy

J. Corry, Domagoj A Vodanovich, L. Wun, 2021, SAGE open medical case reports.

Metastatic Squamous Cell Carcinoma to the Cervical Lymph Nodes From an Unknown Primary Cancer: Management in the HPV Era

J. Shah, R. de Bree, A. Mäkitie, 2020, Frontiers in Oncology.

Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches

E. Genden, J. Werner, R. de Bree, 2013, Head & neck.

Primary central nervous system lymphoma: age and performance status are more important than treatment modality.

J. Corry, G. Quong, A. Wirth, 1998, International journal of radiation oncology, biology, physics.

Randomised trial of radiotherapy with weekly cisplatin or cetuximab in low risk HPV associated oropharyngeal cancer (TROG 12.01) - a Trans-Tasman Radiation Oncology Group study.

R. Fisher, D. Rischin, Lachlan McDowell, 2021, International journal of radiation oncology, biology, physics.

Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).

R. Fisher, L. Peters, D. Rischin, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Role of Palliative Care in Head and Neck Cancer

J. Corry, A. Tiong, 2013 .

Nodal radiation therapy for metastatic melanoma.

J. Corry, J. Ainslie, J. Smith, 1999, International journal of radiation oncology, biology, physics.

International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.

Brian O'Sullivan, Johannes A Langendijk, Cai Grau, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Voice Outcomes after Radiotherapy Treatment for Early Glottic Cancer: Long-Term Follow-Up.

J. Corry, J. Frowen, A. Drosdowsky, 2017, Journal of voice : official journal of the Voice Foundation.

Liposarcoma of the retropharyngeal space

J. Corry, J. Manji, B. Dixon, 2022, ANZ journal of surgery.

Voice outcomes after radiotherapy treatment for early glottic cancer: Assessment using multidimensional tools

Alison Perry, A. Perry, S. Cotton, 2008, Head & neck.

Strategies to reduce long‐term postchemoradiation dysphagia in patients with head and neck cancer: An evidence‐based review

V. Grégoire, A. Eisbruch, M. Hamoir, 2014, Head & neck.

Contemporary management of lymph node metastases from an unknown primary to the neck: II. A review of therapeutic options

E. Genden, J. Werner, R. de Bree, 2013, Head & neck.

Rising prevalence of human papillomavirus–related oropharyngeal cancer in Australia over the last 2 decades

Jonathan R. Clark, Xiaoying Zhang, B. Rose, 2016, Head & neck.

Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma

Jonathan R. Clark, B. Rose, M. Chatfield, 2013, International journal of cancer.

Frequency and prognostic significance of p16INK4A protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma

B. Solomon, D. Rischin, R. Young, 2015, British Journal of Cancer.

Individualised mindfulness‐based stress reduction for head and neck cancer patients undergoing radiotherapy of curative intent: a descriptive pilot study

M. Ftanou, L. Carlson, D. Castle, 2017, European journal of cancer care.

Collaborative action will generate better outcomes.

J. Corry, 2018, The Lancet. Oncology.

Systemic Therapy in Breast Cancer

P. Lønning, J. Corry, 1994, PharmacoEconomics.

What is the best treatment for patients with human papillomavirus–positive and –negative oropharyngeal cancer?

D. Rischin, J. Corry, D. Urban, 2014, Cancer.

Optimising the therapeutic ratio in head and neck cancer.

L. Peters, D. Rischin, J. Corry, 2010, The Lancet. Oncology.

Strategies to overcome accelerated repopulation and hypoxia--what have we learned from clinical trials?

D. Rischin, J. Corry, 2004, Seminars in oncology.

Letter to the editor regarding ACR appropriateness criteria for ipsilateral radiation for squamous cell carcinoma of the tonsil

L. Peters, J. Corry, Chen Liu, 2013, Head & neck.

Impact of primary tumor volume on local control after definitive radiotherapy for head and neck cancer

A. Eisbruch, W. Mendenhall, J. Langendijk, 2013, Head & neck.

Quality of Life, Toxicity and Unmet Needs in Nasopharyngeal Cancer Survivors

J. Ringash, D. Rischin, Lachlan McDowell, 2020, Frontiers in Oncology.

Feeding tubes and dysphagia: Cause or effect in head and neck cancer patients

J. Corry, 2009, Journal of medical imaging and radiation oncology.

Mantle irradiation alone for clinical stage I-II Hodgkin's disease: long-term follow-up and analysis of prognostic factors in 261 patients.

K. Yuen, J. Corry, G. Ryan, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of self-reported smoking status and physician-recorded smoking status among patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

D. Rischin, J. Corry, M. Trinkaus, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The utility of PET/CT in staging and assessment of treatment response of nasopharyngeal cancer

D. Rischin, J. Corry, E. Lau, 2011, Journal of medical imaging and radiation oncology.

'Boomerang' technique: an improved method for conformal treatment of locally advanced nasopharyngeal cancer.

R. Fisher, L. Peters, D. Rischin, 2004, Australasian radiology.

The Changing Demography and Treatment of Nasopharyngeal Carcinoma in Melbourne from 1985–2000

L. Peters, D. Rischin, J. Corry, 2003 .

Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma.

R. Hicks, D. Rischin, J. Corry, 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Current management of xerostomia in head and neck cancer patients.

A. Eisbruch, C. Nathan, P. Strojan, 2023, American journal of otolaryngology.

Introducing: The Red Journal Gray Zone.

A. Zietman, S. Yom, D. Palma, 2017, International Journal of Radiation Oncology, Biology, Physics.

Unilateral radiotherapy treatment for p16/human papillomavirus–positive squamous cell carcinoma of unknown primary in the head and neck

B. Solomon, D. Rischin, R. Young, 2018, The Laryngoscope.

Usefulness of fluorine‐18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck

A. Hogg, J. Matthews, R. Hicks, 2004, Head & neck.

Cytotoxic chemotherapy and radiotherapy in a patient with breast cancer and variegate porphyria (VP)

J. Corry, J. Scarlett, P. Jeal, 1995, Australian and New Zealand journal of medicine.

Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia.

L. Peters, J. Cramb, J. Corry, 2007, International journal of radiation oncology, biology, physics.

Intensity-modulated radiation therapy: First reported treatment in Australasia.

D. L. Joon, J. Cramb, J. Corry, 2002, Australasian radiology.

Intensity-modulated radiotherapy: examples of its utility in head and neck cancer.

L. Peters, D. Rischin, S. Porceddu, 2004, Australasian Radiology.

Radiotherapy for parapharyngeal space tumors.

A. Eisbruch, W. Mendenhall, L. Harrison, 2019, American journal of otolaryngology.

Clinical verification of the superiority of the current International Union Against Cancer staging criteria in an Australian population of patients with nasopharyngeal carcinoma.

R. Fisher, L. Peters, R. Fisher, 2004, Australasian radiology.

Relapse patterns in WHO 2/3 nasopharyngeal cancer: is there a difference between ethnic Asian vs. non-Asian patients?

R. Fisher, L. Peters, D. Rischin, 2006, International journal of radiation oncology, biology, physics.

Oncology scan--nodal regions, nodal regression, and molecular biomarkers: new thinking in head and neck radiation therapy.

G. Sanguineti, S. Yom, J. Thariat, 2014, International journal of radiation oncology, biology, physics.

Outcomes of Routine Intensity Modulated Radiation Therapy Quality Assurance in a Large Head and Neck Cancer Center.

Alan Herschtal, J. Corry, I. D'Costa, 2017, International journal of radiation oncology, biology, physics.

Larynx preservation with primary non‐surgical treatment for loco‐regionally advanced larynx cancer

D. Rischin, J. Corry, I. D'Costa, 2011, Journal of medical imaging and radiation oncology.

Systemic therapy in breast cancer: efficacy and cost utility.

P. Lønning, J. Corry, 1994, PharmacoEconomics (Auckland).